Book Appointment Now
Anti-bribery Policy
Effective date: 01/04/2026
At SIDAPHARM P.C., we are committed to a zero-tolerance approach to bribery and corruption. We comply with applicable anti-bribery legislation, ISO 37001:2025 requirements, and ethical business principles in all activities.
Our anti-bribery policy is based on the following core principles:
• Zero tolerance for offering, giving, soliciting, or accepting bribes or improper advantages.
•Prohibition of facilitation payments, kickbacks, or hidden commissions.
•Prohibition of any activity that may improperly influence business or regulatory decisions.
•Obligation to report suspected or actual bribery concerns
Enforcement
• Maintain documented anti-bribery controls.
• Conduct bribery risk assessments.
• Apply due diligence to suppliers, distributors, consultants, and business partners.
• Provide anti-bribery training.
• Protect whistleblowers and confidential reporting.
Communication and Awareness
This policy is communicated to all employees and relevant stakeholders and is available publicly upon request. Training is conducted during onboarding and at regular intervals.
Review
This policy is reviewed annually or when significant legal, organizational, or operational changes occur.
The Anti-Bribery Policy is communicated within the organization and made available to relevant interested parties.
By adhering to this Anti-Bribery Policy, SIDAPHARM P.C. ensures ethical business conduct, transparency, compliance with applicable anti-bribery requirements, and integrity in all business relationships.
Approved by,
Diana Mochintra
General Manager
At SIDAPHARM P.C., we are committed to a zero-tolerance approach to bribery and corruption. We comply with applicable anti-bribery legislation, ISO 37001:2025 requirements, and ethical business principles in all activities.
Our anti-bribery policy is based on the following core principles:
• Zero tolerance for offering, giving, soliciting, or accepting bribes or improper advantages.
•Prohibition of facilitation payments, kickbacks, or hidden commissions.
•Prohibition of any activity that may improperly influence business or regulatory decisions.
•Obligation to report suspected or actual bribery concerns
Enforcement
• Maintain documented anti-bribery controls.
• Conduct bribery risk assessments.
• Apply due diligence to suppliers, distributors, consultants, and business partners.
• Provide anti-bribery training.
• Protect whistleblowers and confidential reporting.
Communication and Awareness
This policy is communicated to all employees and relevant stakeholders and is available publicly upon request. Training is conducted during onboarding and at regular intervals.
Review
This policy is reviewed annually or when significant legal, organizational, or operational changes occur.
The Anti-Bribery Policy is communicated within the organization and made available to relevant interested parties.
By adhering to this Anti-Bribery Policy, SIDAPHARM P.C. ensures ethical business conduct, transparency, compliance with applicable anti-bribery requirements, and integrity in all business relationships.
Approved by,
Diana Mochintra
General Manager
